Key facts
- It has raised $11.0M; the latest was Seed Round ($7.0M) in May 2025.
- Notable investors include University of Toronto, Johnson & Johnson Innovation - JLABS, Radical Ventures, Avant Bio, Propagator Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Intrepid Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Intrepid Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Intrepid Labs
Operator of a biotechnology research company intended to fast-track therapeutics development. The company's platform leverages active machine learning, advanced robotics, and deep pharmaceutical expertise to revolutionize the design of next-generation drug products, enabling the pharmaceutical market to re-engineer the drug formulation process.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2023
- Employees
- 23
- Website
- intrepidlabs.tech/
- Ownership
- Privately Held (backing)
Intrepid Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Intrepid Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Intrepid Labs in its N-PORT filings yet. We sweep new filings monthly.